Correspondence 0001493152-25-005139 from Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)

Syra Health Corp (SYRA) (CIK 0001922335)
Date: Feb. 6, 2025 · CIK: 0001922335 · Accession: 0001493152-25-005139

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-284498

Date

January 24, 2025

Author

SYRA

Form

CORRESP

Company

Syra Health Corp (SYRA) (CIK 0001922335)

Letter

SYRA HEALTH CORP.

Keystone Way N. #201

Carmel, IN 46032

February 6, 2025

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Jenna Hough

Re: Syra Health Corp.

Registration Statement on Form S-1

Filed January 24, 2025

File No. 333-284498

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Syra Health Corp. (the “Company”) respectfully requests that the effective date of the registration statement referred to above (the “Registration Statement”) be accelerated so that it becomes effective at 4:30 p.m., Eastern Time, on February 7, 2025, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 643-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Sincerely,
SYRA
HEALTH CORP.

Show Raw Text

CORRESP
1
filename1.htm

SYRA
HEALTH CORP.

1119
Keystone Way N. #201

Carmel,
IN 46032

February
6, 2025

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Jenna Hough

 Re: Syra
                                            Health Corp.

    Registration
                                            Statement on Form S-1

    Filed
                                            January 24, 2025

    File
                                            No. 333-284498

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Syra Health Corp. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above (the “Registration Statement”)
be accelerated so that it becomes effective at 4:30 p.m., Eastern Time, on February 7, 2025, or as soon thereafter as possible.

Please
notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 643-3067 as soon as possible
as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Sincerely,

    SYRA
    HEALTH CORP.

    By:
    /s/
    Deepika Vuppalanchi

    Name:
     Deepika
    Vuppalanchi

    Title:
    Chief
    Executive Officer

    -1-

SecProbe.io